Author:
Kramer Caroline K.,Ye Chang,Campbell Sara,Retnakaran Ravi
Subject
Cardiology and Cardiovascular Medicine
Reference34 articles.
1. Food and Drug Administration. Guidance for industry: diabetes mellitus—evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. Silver Spring, Maryland: Food and Drug Administration, December 2008. Available at: www.fda.gov/downloads/Drugs/Guidances/ucm071627.pdf. Accessed November 23, 2017.
2. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus;Scirica;N Engl J Med,2013
3. Alogliptin after acute coronary syndrome in patients with type 2 diabetes;White;N Engl J Med,2013
4. Role of diabetes in congestive heart failure: the Framingham Study;Kannel;Am J Cardiol,1974
5. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme;MacDonald;Eur Heart J,2008
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献